CHICAGO — EvoEndo Inc. said healthcare providers have completed more than 3,000 sedation-free transnasal endoscopy procedures using its endoscopy system as adoption expands across the United States.
The EvoEndo Endoscopy System is now in use at more than 70 locations nationwide, including facilities in Boston, Cleveland, Milwaukee, Birmingham, Orlando and San Francisco. More than 100 practitioners have adopted the platform.
Several hospitals have performed more than 300 procedures using the system, including Children’s Mercy Kansas City and Phoenix Children’s Hospital.
“Reaching 3,000 cases is an important milestone, but what matters most is what it represents for patients, families, and physicians,” said Jonathan Hartmann, Chief Executive Officer of EvoEndo. “Every case reflects greater access to sedation-free endoscopy and the trust our partners place in EvoEndo.”
Transnasal endoscopy allows physicians to examine the upper gastrointestinal tract without sedation. The procedure can eliminate the need for a recovery room and allow patients to leave shortly after it is completed.
Eitan Rubinstein, M.D., Assistant Professor of Pediatrics at Harvard Medical School and Attending Physician in the Department of Gastroenterology and Nutrition at Boston Children’s Hospital, said the system offers a less invasive option for treating and monitoring patients with eosinophilic esophagitis.
“We have been thrilled to offer our patients a less invasive option for managing and monitoring their eosinophilic esophagitis,” Rubinstein said.
Aravind Thavamani, M.D., Pediatric Gastroenterologist at University Hospitals Rainbow Babies & Children’s Hospital, said the technology has changed how he approaches endoscopy in pediatric patients.
“TNE has changed the way I approach endoscopy in my pediatric patients — no sedation, no recovery room, and a child who walks out the door minutes after the procedure,” Thavamani said. “EvoEndo’s platform gives me the tools to make that a reality with enhanced diagnostic capability.”
